Inhibition of β-amyloid-induced neurotoxicity by planar analogues of procyanidin B3

Bioorg Med Chem Lett. 2019 Sep 15;29(18):2659-2663. doi: 10.1016/j.bmcl.2019.07.038. Epub 2019 Jul 23.

Abstract

Reactive oxygen species (ROS) are known to be produced during the amyloid beta (Aβ) aggregation process. Both ROS production and Aβ fibril formation can result in nerve cell injury. Proanthocyanidins are oligomers of catechin that can act as inhibitors of Aβ aggregation. Procyanidin B3 (Cat-Cat), the dimer of (+)-catechin, can easily cross the blood-brain barrier. Previously, we synthesized two derivatives of Cat-Cat, namely Cat-PCat and PCat-PCat, in which the geometry of one or both catechin molecules in Cat-Cat was constrained to be planar. The antioxidative activities of Cat-PCat and PCat-PCat were found to be stronger than that of Cat-Cat, with PCat-PC at exhibiting the most potent activity. These compounds are predicted to protect against Aβ-induced neurotoxicity via inhibition of Aβ aggregation as well as by antioxidative effects toward Aβ-induced intracellular ROS generation. PCat-PCat exhibited the most potent neuroprotective effects against Aβ-induced cytotoxicity, which resulted from inhibition of β-sheet structure formation during the Aβ aggregation process. PCat-PCat may be a promising lead compound for the treatment of Alzheimer's disease.

Keywords: Alzheimer’s disease; Amyloid beta; Catechin; Proanthocyanidin; Procyanidin; Reactive oxygen species.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / metabolism
  • Amyloid beta-Peptides / antagonists & inhibitors*
  • Amyloid beta-Peptides / metabolism
  • Antioxidants / chemical synthesis
  • Antioxidants / chemistry
  • Antioxidants / pharmacology*
  • Biflavonoids / chemical synthesis
  • Biflavonoids / chemistry
  • Biflavonoids / pharmacology*
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / metabolism
  • Catechin / chemical synthesis
  • Catechin / chemistry
  • Catechin / pharmacology*
  • Dose-Response Relationship, Drug
  • Humans
  • Molecular Structure
  • Neuroprotective Agents / chemical synthesis
  • Neuroprotective Agents / chemistry
  • Neuroprotective Agents / pharmacology*
  • Proanthocyanidins / chemical synthesis
  • Proanthocyanidins / chemistry
  • Proanthocyanidins / pharmacology*
  • Protein Aggregates / drug effects
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism
  • Structure-Activity Relationship

Substances

  • Amyloid beta-Peptides
  • Antioxidants
  • Biflavonoids
  • Neuroprotective Agents
  • Proanthocyanidins
  • Protein Aggregates
  • Reactive Oxygen Species
  • procyanidin B3
  • Catechin